SEARCH

SEARCH BY CITATION

References

  • ARAI, H., HORI, S., ARAMOI, I., OHKUBO, H. & NAKANISHI, S. (1990). Cloning and expression of a cDNA encoding an endothelin receptor. Nature, 348, 730732.
  • D'ORLÉANS-JUSTE, P., TÉLÉMAQUE, S. & CLAING, A. (1991a). Different pharmacological profiles of big-endothelin-3 and big-endothelin-1 in vivo and also in vitro through a phosphoramidon-sensitive conversion to endothelin-1. Br. J. Pharmacol., 104, 440444.
  • D'ORLÉANS-JUSTE, P., LINDBURY, P.S., TÉLÉMAQUE, S., WARNER, T.D. & VANE, J.R. (1991b). Human big-endothelin releases prostacyclin in vivo and in vitro. J. Cardiovasc. Pharmacol., 17 (Suppl 7), S251S255.
  • DOUGLAS, S.A. & HILEY, C.R. (1990). Responses to endothelin-1, human proendothelin (1–38) and porcine proendothelin (1–39) in the rat on intravenous administration and in the blood perfused mesentery. Neurochem. Int., 4, 445454.
  • FAGNY, C., MICHEL, A., LEONARD, I., BERKENBOOM, G., FONTAINE, J. & DESCHODT-LANCKMAN, M. (1991). In vitro degradation of endothelin-1 by endopeptidase 24.11 (enkephalinase). Peptides, 12, 773778.
  • FUKURODA, T., NOGUCHI, K., TSUCHIDA, S., NISHIKIBE, M., IKEMOTO, F., OKADA, K. & YANO, M. (1990). Inhibition of biological actions of big endothelin-1 by phosphoramidon. Biochem. Biophys. Res. Commun., 172, 390395.
  • GARDINER, S.M., KEMP, P.A. & BENNETT, T. (1992a). Inhibition by phosphoramidon of the regional haemodynamic effects of proendothelin-2 and -3 in conscious rats. Br. J. Pharmacol., 107, 584590.
  • GARDINER, S.M., KEMP, P.A., COMPTON, A.M. & BENNETT, T. (1992b). Coeliac haemodynamic effects of endothelin-1, endothelin-3, proendothelin-1[1–38] and proendothelin-3[1–41] in conscious rats. Br. J. Pharmacol., 106, 483488.
  • GOMEZ-SANCHEZ, C.E., COZZA, E.N., FOECKLING, M.F., CHIOU, S. & FERRIS, M.W. (1990). Endothelin receptor subtypes and stimulation of aldosterone secretion. Hypertension, 15, 744747.
  • HILEY, C.R., PELTON, J.T. & MILLER, R.C. (1989). Effects of endothelin on field stimulated rat vas deferens and guinea pig ileum. Br. J. Pharmacol., 96, 104P.
  • HISAKI, K., MATSUMURA, Y., IKEGAWA, R., NISHIGUCHI, S., HASASHI, K., TAKAOKA, M. & MOROMOTO, S. (1991). Evidence for Phosphoramidon-sensitive conversion of big endothelin-1 to endothelin-1 in isolated rat mesenteric artery. Biochem. Biophys. Res. Commun., 177, 11271132.
  • INOUE, A., YANAGISAWA, M., KIMURA, S., KASUYA, Y., MIYAUCHI, K., GOTO, K. & MASAKI, T. (1989). The human endothelin family; three structurally and pharmacologically distinct isopeptides predicted by three separate genes. Proc. Natl. Acad. Sci. U.S.A., 86, 28632867.
  • JAFFER, F.E., KNAUSS, C., POPTIC, E. & ABBOUD, H.E. (1990). Endothelin stimulates PDGF secretion in cultured human mesangial cells. Kidney Int., 38, 11931198.
  • JONES, C.R., HILEY, C., PELTON, J.T. & MOHR, M. (1989). Autoradiographic visualization of the binding sites for [I125] endothelin in rat and human brain. Neurosci. Lett., 97, 276279.
  • KASHIWABARA, T., INAGAKI, Y., OHTA, H., IWAMATSU, A., NOMIZU, M., MORITA, A. & NISHIKORI, K. (1989). Putative precursors of endothelin have less vasoconstrictor activity in vitro but a potent pressor effect in vivo. FEBS Lett., 247, 7376.
  • KLOOG, Y. & SOKOLOVSKY, M. (1989). Similarities in mode and sites of action of sarafotoxins and endothelins. Trends Pharmacol. Sci., 10, 212214.
  • Le de GOUVILLE, MONNIER A.C. & CAVERO, I. (1991). Differential pharmacological profile of endothelin-1 and its precursor, big endothelin. J. Cardiovasc. Pharmacol., 17 (Suppl. 7), S362365.
  • MAGGI, C.A., GIULIANI, S., PATACCHINI, R., ROVERO, P., GIACHETTI, A. & MELI, A. (1989). The activity of peptides of the endothelin family in various mammalian smooth muscle preparations. Eur. J. Pharmacol., 174, 2331.
  • MATSUMURA, Y., IKEGAWA, R., TAKAOKA, M. & MORIMOTO, S. (1990a). Conversion of porcine big endothelin to endothelin by an extract from the porcine aortic endothelial cells. Biochem. Biophys Res. Commun., 167, 203210.
  • MATSUMURA, Y., HISAKI, K., TAKAOKA, M. & MORIMOTO, S. (1990b). Phosphoramidon, a metalloproteinase inhibitor, suppresses the hypertensive effect of big endothelin-1. Eur. J. Pharmacol., 185, 103106.
  • MATSUMURA, Y., IKEGAWA, R., TSUKAHARA, Y., TAKAOKA, M. & MORIMOTO, S. (1991). n-Ethylmaleimide differentiates endothelin converting activity by two types of metalloproteinases derived from vascular endothelial cells. Biochem. Biophys. Res. Commun., 178, 531538.
  • MATSUMURA, Y., TSUKAHARA, Y., KUNINOBU, K., TAKAOKA, M. & MORIMOTO, S. (1992). Phosphoramidon sensitive endothelin-converting enzyme in vascular endothelial cells converts big endothelin-1 and big endothelin-3 to their mature form. FEBS Lett., 305, 8690.
  • MATTERA, C.G., EGLEZOS, A., CUCCHI, P., RENZETTI, A.R. & MISRAHI, J. (1992a). Phosphoramidon-sensitive conversion of human proendothelin in vivo: effect on pressure and plasma prostacyclin. Br. J. Pharmacol., 107, 161P.
  • MATTERA, C.G., RENZETTI, A.R. & MIZRAHI, J. (1992b). Metalloprotease dependent conversion of human proendothelin in vivo. Pharmacol. Res., 26 (Suppl. 1), 159.
  • McKAY, K.O., BLACK, J.L. & ARMOUR, C.L. (1992). Phosphoramidon potentiates the contractile response to endothelin-3, but not endothelin-1 in isolated airway tissue. Br. J. Pharmacol., 105, 929932.
  • McMAHON, E.G., PALOMO, M.A., MOORE, W.M., McDONALD, J.F. & STERN, M.K. (1991). Phosphoramidon blocks the pressor activity of porcine big endothelin 1(1–39) in vivo and conversion of big endothelin 1 (1–39) to endothelin 1 (1–21) in vitro. Proc. Natl. Acad. Sci. U.S.A., 88, 703707.
  • MILLER, V.M., REDFIELD, M.M. & BURNETT, J.C. (1989). Integrated cardiac, renal and endocrine action of endothelin. J. Clin. Invest., 83, 317320.
  • OKADA, K., MIYAZAKI, J., TAKADA, J., ARAI, Y., MATSUYAMA, K., YAMAKI, T. & YANO, M. (1990). Conversion of Big-endothelin-1 by membrane-bound metalloendopeptidase in cultured bovine endothelial cells. Biochem. Biophys. Res. Commun., 171, 11921198.
  • OKADA, K., TAKADA, J., ARAI, Y., MATSUYAMA, K. & YANO, M. (1991). Importance of the C-terminal region of Big-endothelin-1 for specific conversion by phosphoramidon-sensitive endothelin converting enzyme. Biochem. Biophys. Res. Commun., 180, 10191023.
  • POLLOCK, D.M. & OPGENORTH, T.J. (1991). Evidence for metalloprotease involvement in the in vivo effects of big Endothelin 1. Am J. Physiol., 261, R257R263.
  • PONS, F., TOUVAY, C., LAGENTE, V., MENCIA-HUERTA, J.M. & BRAQUET, P. (1991). Bronchopulmonary and pressor activities of endothelin-1 (ET-1), ET-2, ET-3 and Big ET-1 in the Guinea Pig. J. Cardiovasc. Pharmacol., 17 (Suppl. 7), S326S328.
  • POWER, R.F., WHARTON, J., SALAS, S.P., KANSE, S., GHATEI, M., BLOOM, S.R. & POLAK, J.M. (1989). Autoradiographic localisation of endothelin binding sites in human and porcine coronary arteries. Eur. J. Pharmacol., 160, 199200.
  • RANDALL, M.D. (1991). Vascular activities of the endothelins. Pharmacol. Ther., 50, 7393.
  • SAKURAI, T., YANAGISAWA, M., TAUWA, Y., MIYAZAKI, H., KIMURA, S., GOTO, K. & MASAKI, T. (1990). Cloning of cDNA encoding a non-isopeptide selective sub-type of the endothelin receptor. Nature, 348, 732735.
  • TAKADA, J., OKADA, K., IKEGAWA, T., MATSUYAMA, K. & YANO, M. (1991). Phosphoramidon-sensitive endothelin-converting enzyme in the cytosol of cultured bovine endothelial cells. Biochem. Biophys. Res. Commun., 176, 860865.
  • TÉLÉMAQUE, S. & D'ORLÉANS-JUSTE, P. (1991). Presence of a phosphoramidon-sensitive endothelin-converting enzyme which converts Big-Endothelin-1, but not Big-Endothelin-3 in the rat vas deferens. Naunyn-Schmied. Arch. Pharmacol., 344, 500507.
  • VIJAYARAGHAVAN, J., SCICLI, A.G., CARRETTERO, O.A., SLAUGHTER, C., MOOMAW, C. & HERSH, L.B. (1990). The hydrolysis of endothelins by neutral endopeptidase 24.11 (enkefalinase). J. Biol. Chem., 265, 1415014155.
  • WIKLUND, N.P., OHLEN, A., WIKLUND, C.U., HEDQVIST, P. & GUSTAFSSON, L.E. (1990). Endothelin modulation of neuroeffector transmission in rat and guinea pig vas deferens. Eur. J. Pharmacol., 185, 2533.
  • YANAGISAWA, M., KURIHARA, H., KIMURA, S., TONOBE, Y., KOBAYASHI, M., MITSUI, Y., YAZAKI, Y., GOTO, K. & MASAKI, T. (1988). A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature, 32, 411415.
  • YANAGISAWA, M. & MASAKI, T. (1989). Endothelin, a novel endothelium-derived peptide. Biochem. Pharmacol., 38, 18771883.
  • YANO, M., OKADA, K., TAKADA, J., HIOKI, Y., MATSUYAMA, K., FUKURODA, T., NOGUCHI, K., NISHIKIBE, M. & IKEMOTO, F. (1991). Endothelin-converting enzyme and its in vitro and in vivo inhibition. J. Cardiovasc. Pharmacol., 17 (Suppl. 7), S26S28.